Furthermore, drugs such as resveratrol and paclitaxel have been shown to attenuate inflammation in AKI by inhibiting MALAT1 expression, thereby improving the prognosis of SA-AKI (Xu et al., 2020; Wang et al., 2021b). Here, MALAT1 is linked to acute kidney injury.